Screening and Therapeutic Monitoring of Multiple Myeloma by MALDI-TOF MS Analysis

Abroad (travel likely)Recruiting

Conditions

Monoclonal Gammopathies · Multiple Myeloma · M-protein

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong, China
Contact: Study coordinator (Hongwei Zhou, Professor) · hzhou@smu.edu.cn · 18688489622

Study leads

Hongwei Zhou, Professor
Study Chair
Zhujiang Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Promoting Diagnosis and Management of AL in Italy (ProDigALIty)

AL Amyloidosis · Smoldering Multiple Myeloma · Monoclonal Gammopathy of Undetermined Significance

Abroad (travel likely)Recruiting

Bari, Italy · Catania, Italy

A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH

Multiple Myeloma · Amyloidosis · Cryoglobulinemia

Abroad (travel likely)Recruiting

Beijing, China

Investigating the Pathogenic Role of N-glycosylation in AL Amyloidosis: Molecular Bases, Diagnosis, and Treatment

AL Amyloidosis · MGUS · Multiple Myeloma

Abroad (travel likely)Recruiting

Pavia, Italy

Characteristics and Clinical Significance of Gut Microbiota in Patients With Monoclonal Gammopathy

Monoclonal Gammopathy of Undetermined Significance (MGUS) · Intestinal Flora · Multiple Myeloma

Abroad (travel likely)Recruiting

Guanzhou, China